Searchable abstracts of presentations at key conferences in endocrinology

ea0056p548 | Obesity | ECE2018

Oxidized low-density lipoprotein (oxLDL) as a possible biomarker of cardiovascular diseases in obese subjects

Parreno Elena , Fornovi Aisa , Ballester Raul , Martinez Luz , Aviles Clara , Martinez Mariana , Arjonilla Elena

Introduction: oxLDL are produced from the oxidation of low density lipoprotein (LDL) by macrophages and endothelial cells, becoming cytotoxic and immunogenic. They are also a potent inhibitor of the macrophages mobility, contributing to the vascular wall progressive inflammatory infiltration and atherosclerosis formation. Weight loss can prevent atherosclerotic plaque progression of and acute coronary events in obese subjects, so that oxLDL could be used a biomarker of cardiov...

ea0035p575 | Endocrine tumours and neoplasia | ECE2014

Chemoembolization as a locoregional treatment for metastatic disease on a liver transplant from a bronchial carcinoid neuroendocrine tumor

Baena Juan Manuel Guardia , Luque Pedro Segura , Alonso Aurora Aragon , Justo Aisa Fornovi , Cascales Ana Belen Hernandez , Sajardo Raul Ballester , Gonzalez Luz Martinez , Espallardo Maria de los Angeles Campillo , Ortega Paloma Portillo , Monllor Marta Arraez , Gil Maria Dolores Hellin , Gomez Mercedes Ferrer , Sanchez Jose Ramon Cuenca , Conesa Juan Madrid , Martinez Antonio Hernandez , Masso Francisco Javier Tebar

Introduction: We present the results of chemoembolization used as a locoregional treatment for liver metastases (on a transplanted liver) from a bronchial carcinoid neuroendocrine tumor with stage IV disease progression.Case report: A 60-year-old man diagnosed of bronchial carcinoid NET in 2002, underwent surgery by lung lobectomy and excision of lymph node metastases. Treated also with somatostatin analogues (SA) after subsequent discovery of liver meta...